Professor Gerrit Frommeyer

Back

Professor Gerrit Frommeyer

Hospital of the Westfälische Wilhelms-University, Department of Cardiology and Angiology, Münster (Germany)

Presentations

Beneficial electrophysiologic effects of sacubitril in different arrhythmia syndromes

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pathophysiology and Mechanisms

Session: Arrhythmias, General ePosters

Access

Dexmedetomidine reduces ventricular arrhythmias in a model of drug-induced QT-prolongation

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Antiarrhythmic Drug Treatment

Session: Arrhythmias, General ePosters

Access

Arrhythmogenic effects of non-steroidal anti-inflammatory drugs (NSAID)

Event: ESC CONGRESS 2019

Topic: Risk Factors and Risk Assessment

Session: Basic Science

Access

Time-to-isolation-guided cryoballoon pulmonary vein isolation reduces esophageal and mediastinal alterations detected by endoscopic ultrasound

Event: ESC CONGRESS 2019

Topic: Rhythm Control, Catheter Ablation

Session: New insights in atrial fibrillation ablation: techniques and complications

Access

Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy - data from the German device Registry

Event: ESC CONGRESS 2019

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Arrhythmia in cardiomyopathy

Access

Long-term single-center experience of transvenous defibrillator therapy in children and adolescents

Event: ESC Congress 2018

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Implantable cardioverter defibrillation : treatment outcomes

Access

Ranolazine reduces levosimendan-mediated atrial fibrillation in an experimental whole-heart model

Event: ESC Congress 2018

Topic: Antiarrhythmic Drug Treatment

Session: Arrhythmia mechanisms - General

Access

Electrophysiologic profile of propofol in isolated rabbit hearts

Event: ESC Congress 2018

Topic: Antiarrhythmic Drug Treatment

Session: Arrhythmia mechanisms - General

Access

Safe electrophysiologic profile of the potential novel antiarrhythmic drug antazoline

Event: ESC CONGRESS 2016

Topic: Ventricular arrhythmias

Session: Ventricular arrhythmia, ICD and remote monitoring

Access

Interactions of digitalis and class-III antiarrhythmic drugs: amiodarone versus dronedarone

Event: ESC CONGRESS 2016

Topic: Antiarrhythmic drugs

Session: Miscellaneous in arrhythmia

Access

Professor Gerrit Frommeyer

Contributor content

Beneficial electrophysiologic effects of sacubitril in different arrhythmia syndromes

Dexmedetomidine reduces ventricular arrhythmias in a model of drug-induced QT-prolongation

Arrhythmogenic effects of non-steroidal anti-inflammatory drugs (NSAID)

Time-to-isolation-guided cryoballoon pulmonary vein isolation reduces esophageal and mediastinal alterations detected by endoscopic ultrasound

Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy - data from the German device Registry

Long-term single-center experience of transvenous defibrillator therapy in children and adolescents

Ranolazine reduces levosimendan-mediated atrial fibrillation in an experimental whole-heart model

Electrophysiologic profile of propofol in isolated rabbit hearts

Safe electrophysiologic profile of the potential novel antiarrhythmic drug antazoline

Interactions of digitalis and class-III antiarrhythmic drugs: amiodarone versus dronedarone

This platform is supported by